United Kingdom Continuous Glucose Monitoring Market Size
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2018 - 2022 |
| CAGR | 15.90 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
United Kingdom Continuous Glucose Monitoring Market Analysis
The United Kingdom Continuous Glucose Monitoring Market is expected to register a CAGR of about 15.9% and reach a value of about USD 580 million over the forecast period.
According to The British Diabetic Association, the COVID-19 pandemic continued to have a huge impact on society. However, research and data showed that people with diabetes were disproportionately affected by COVID-19, particularly in terms of poorer outcomes when contracting the virus; that's why preventing or delaying cases of diabetes was more important than ever. The pandemic also highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care through virtual consultations between healthcare providers and people with diabetes and diabetes technology. Crisis management has created unprecedented interest in remote care from both patients and providers.
Continuous Glucose Monitoring tests glucose concentration in the blood (glycemia). Particularly important in diabetes management, a blood glucose test is typically performed to determine the fluctuation in blood glucose level to take or alter the medication accordingly, especially for insulin users. Achieving optimum glycemic results can be very difficult without frequent monitoring of blood glucose levels.
Furthermore, the current continuous glucose Monitoring can either retrospectively display the trends in blood glucose levels by downloading the data or give a real-time picture of glucose levels through receiver displays. The newest CGM models, the Abbott Freestyle Libre 3 and the Dexcom G7, overcame many technical barriers. Technological advances such as Eversense E3 CGMs have significantly improved the ability of providers and patients to manage diabetes, thereby enhancing the market prospects in the years to come.
United Kingdom Continuous Glucose Monitoring Market Trends
Growing Diabetes Population in the United Kingdom
The United Kingdom diabetes Population is expected to increase with a CAGR greater than 2% over the forecast period.
In the United Kingdom, the prevalence of diabetes has increased dramatically during the last two decades, driven by the increased prevalence of obesity and lifestyle changes. The country also has the highest obese population, a prominent cause of Type 2 diabetes. According to The British Diabetic Association Diabetes Prevalence, the latest data shows an increase in the number of people living with a diabetes diagnosis in the United Kingdom: an increase of more than 150,000 from the previous year. It is estimated that more than 13.6 million people are at increased risk of type 2 diabetes in the United Kingdom. At this rate, the number of people with diabetes, including the undiagnosed population, is expected to rise to 5.5 million by 2030, as per IDF 2021 statistics.
The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of market growth. Leading manufacturers focus on technological innovations and develop advanced products to gain a substantial market share. Technological innovations and advancements offer many conveniences in maintaining blood glucose levels. The vast range of apps in the diabetes field supports the adoption of lifestyle interventions for the prevention and management of diabetes, the evaluation of blood glucose control quality, and the dosing of insulin. Integration of Continuous Glucose Monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, thereby enhancing the market prospects in the years to come.
The sensors segment is expected to hold the highest share over the forecast period
The sensors segment is expected to register a CAGR of 15.8% over the forecast period.
Continuous Glucose Monitoring Devices are automated glucose monitoring systems that consist of a small device that can be worn on the body and held on by an adhesive patch. The sensor part of the device has a cannula inserted into the top layer of skin and uses interstitial fluid samples to check glucose levels. Sensors are connected to a transmitter that can send data wirelessly to a dedicated mobile receiving device or smartphone. Continuous Glucose Monitoring sensors use glucose oxidase to detect blood sugar levels. Sensors are the most important part of Continuous Glucose Monitoring devices.
Researchers are trying to find and develop alternatives to electrochemical-based glucose sensors and create more affordable, minimally invasive, and user-friendly CGM sensors. Optical measurement is a promising platform for glucose sensing. Some technologies have been reported to have high potential in continuous glucose sensing, including spectroscopy, fluorescence, holographic technology, etc. Eversense, a CGM sensor based on fluorescence sensing developed by Senseonics Company, has a much longer lifespan than electrochemical sensors. Technological advancements to improve the accuracy of the sensors are expected to drive segment growth during the forecast period.
The National Service Framework (NSF) program is improving services by setting national standards to drive service quality and tackle variations in care. The Association of British HealthTech Industries (ABHI) launched a diabetes section, enabling diabetes technology companies to work together in the first forum of its kind. The ABHI group is for any health technology company interested in diabetes care, from CGM and insulin pumps to apps. Such advantages are likely to drive segment growth over the forecast period.
United Kingdom Continuous Glucose Monitoring Industry Overview
The United Kingdom Continuous Glucose Monitoring Market is consolidated, with few significant players. There have been constant innovations driven by manufacturers such as Abbott, Dexcom, Medtronic, etc., while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.
United Kingdom Continuous Glucose Monitoring Market Leaders
Abbott
Medtronics
Dexcom
GlySens
Ascensia
*Disclaimer: Major Players sorted in no particular order
United Kingdom Continuous Glucose Monitoring Market News
- October 2022: Abbott announced that a new study published in The New England Journal of Medicine demonstrated that for adults with Type-1 diabetes and suboptimal glycemic control, Abbott's FreeStyle Libre 2 glucose monitoring system provided significant reductions in glycated hemoglobin (HbA1c) compared to self-monitoring of blood glucose, which were sustained for the study duration of 24 weeks. The FreeStyle Libre 2 system was also linked to improvements in participant-reported quality of life outcomes, including overall satisfaction and reduced burden associated with glucose monitoring.
- April 2022: Dexcom released G7 in the United Kingdom. The company announced that the G7 is available for people with diabetes aged two years and older in the United Kingdom. Dexcom G7 has the fastest sensor warmup with no finger sticks or scanning required. It is clinically proven to lower A1C and reduce hyper- and hypoglycemia, supported by more peer-reviewed and clinical research.
Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Component
5.1.1 Sensors
5.1.2 Durables
6. MARKET INDICATORS
6.1 Type-1 Diabetes Population
6.2 Type-2 Diabetes Population
7. COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Abbott Diabetes Care
7.1.2 Dexcom Inc.
7.1.3 Medtronic PLC
7.1.4 Ascensia Diabetes Care
7.1.5 Eversense
7.1.6 GlySens
- *List Not Exhaustive
7.2 Company Share Analysis
7.2.1 Abbott Diabetes Care
7.2.2 Dexcom Inc.
7.2.3 Medtronic PLC
7.2.4 Other Company Share Analyses
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
United Kingdom Continuous Glucose Monitoring Industry Segmentation
Achieving optimum glycemic results can be very difficult without frequent monitoring of blood glucose levels. A continuous glucose monitor tracks blood sugar levels 24 hours a day. It collects readings automatically every five to 15 minutes and detects trends and patterns to provide a complete picture of diabetes. The United Kingdom Continuous Glucose Monitoring Market is segmented into Component (Sensors and Durables). The report offers the value (USD) and volume (Units) for the above segments.
| Component | |
| Sensors | |
| Durables |
Frequently Asked Questions
What is the current United Kingdom Continuous Glucose Monitoring Market size?
The United Kingdom Continuous Glucose Monitoring Market is projected to register a CAGR of 15.90% during the forecast period (2024-2029)
Who are the key players in United Kingdom Continuous Glucose Monitoring Market?
Abbott, Medtronics, Dexcom, GlySens and Ascensia are the major companies operating in the United Kingdom Continuous Glucose Monitoring Market.
What years does this United Kingdom Continuous Glucose Monitoring Market cover?
The report covers the United Kingdom Continuous Glucose Monitoring Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the United Kingdom Continuous Glucose Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
United Kingdom Continuous Glucose Monitoring Industry Report
Statistics for the 2024 United Kingdom Continuous Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. United Kingdom Continuous Glucose Monitoring analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
